NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.400
-0.310 (-11.44%)
At close: Aug 13, 2025, 4:00 PM
2.470
+0.070 (2.92%)
Pre-market: Aug 14, 2025, 8:58 AM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $19.36 million as of August 14, 2025. Its market cap has increased by 3.98% in one year.
Market Cap
19.36M
Enterprise Value
21.29M
1-Year Change
3.98%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $19.36M, a decrease of -1.16%. That is a compound annual growth rate of -0.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 19.36M | -42.25% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |